XORTX Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
Frequently asked questions
To buy XORTX Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for XORTX Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for XORTX Therapeutics Inc. is XRTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
XORTX Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade XORTX Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, XORTX Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include XORTX Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like XORTX Therapeutics Inc. or others.